Sodium Iodide → HCID 11555269, compound
Reaction equation
NS(N)(=O)=O.Cl[CH2:7][CH2:8][CH2:9][S:10]([N:13]1[CH2:18][CH2:17][CH:16]([C:19]2[C:27]3[C:22](=[C:23]([C:34]([NH2:36])=[O:35])[CH:24]=[C:25]([C:28]4[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=4)[CH:26]=3)[NH:21][CH:20]=2)[CH2:15][CH2:14]1)(=[O:12])=[O:11].[NH:37]1[CH2:42][CH2:41][CH2:40][CH2:39][CH2:38]1.C([O-])([O-])=O.[K+].[K+].[Na+].[I-]>>[C:28]1([C:25]2[CH:26]=[C:27]3[C:22](=[C:23]([C:34]([NH2:36])=[O:35])[CH:24]=2)[NH:21][CH:20]=[C:19]3[CH:16]2[CH2:17][CH2:18][N:13]([S:10]([CH2:9][CH2:8][CH2:7][N:37]3[CH2:42][CH2:41][CH2:40][CH2:39][CH2:38]3)(=[O:12])=[O:11])[CH2:14][CH2:15]2)[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=1Participants
6
Procedure
Following the general procedure for aminosulfonamide formation outlined in example 2, 3-{1-[(3-chloropropyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide (62 mg, 0.13 mmol) and piperidine (55.25 mg, 0.65 mmol) were allowed to react in the presence of K2CO3 (72 mg, 0.56 mmol) and NaI (Cat. 2.0 mg). The resulting residue purified by reverse phase HPLC eluting with 10% B to 80% B, where A=H2O (0.1% trifluoroacetic acid) and B=CH3CN (0.1% trifluoroacetic acid) to give the title compound (31.5 mg, 46%).
Workup
- customThe resulting residue purified by reverse phase HPLC
- washeluting with 10% B to 80% B, where A=H2O (0.1% trifluoroacetic acid) and B=CH3CN (0.1% trifluoroacetic acid)
Sources & evidence
- ORD record
- ord-660e12d72d5649c59564a87854be29c6
- Source dataset
- uspto-grants-2010_12
- Patent number
- US07858796B2
Reaction notes
Loading…